Medicare Enrolled

Dr. Gatoya Simpson, M.D.

Anesthesiology · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
13009 GULF COMMERCE DR STE 200, Houston, TX 77034
8329162075
In practice since 2015 (10 years)
NPI: 1326425240 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Simpson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Simpson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Simpson

Dr. Gatoya Simpson is an anesthesiology specialist in Houston, TX, with 10 years of NPI registration. Based on federal Medicare data, Dr. Simpson performed 1,937 Medicare services across 880 unique beneficiaries.

Between the years covered by Open Payments, Dr. Simpson received a total of $13,479 from 42 pharmaceutical and/or device companies across 312 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Simpson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice ▲ Top 5% volume in TX $13,479 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,937
Medicare services
Top 5% in TX for anesthesiology
880
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~194 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
338 $95 $336
Midazolam injection, per 1 mg
Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments.
331 $0 $10
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
310 $65 $236
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
170 $59 $349
Injection, methylprednisolone acetate, 40 mg 157 $6 $50
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
120 $0 $10
Contrast dye for imaging, lower concentration 94 $0 $10
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
68 $11 $37
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
52 $116 $434
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
51 $202 $694
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
35 $0 $5
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
33 $42 $162
Fluoroscopic guidance for needle placement
Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure.
33 $59 $310
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
30 $56 $215
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
30 $186 $850
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
30 $94 $439
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
20 $448 $2,020
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
19 $248 $1,109
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
16 $158 $673
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,479
Total received (2019-2024)
Avg $2,246/year across 6 years
Top 3% in TX for anesthesiology
42
Companies
312
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,479 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,693
2023
$1,489
2022
$3,788
2021
$1,838
2020
$1,075
2019
$1,596

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$3,034
Saluda Medical Americas, Inc.
$1,585
Abbott Laboratories
$1,446
Nevro Corp.
$884
Collegium Pharmaceutical, Inc.
$868
PAINTEQ LLC
$823
Medtronic USA, Inc.
$817
Spinal Simplicity, LLC
$757
Medtronic, Inc.
$513
Nalu Medical, Inc.
$368
BOSTON SCIENTIFIC CORPORATION
$304
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$225
GRT US Holding, Inc.
$202
MML US, Inc.
$183
Biohaven Pharmaceutical Holding Company Ltd.
$165
AbbVie Inc.
$139
BIOTRONIK NRO, Inc.
$135
Novo Nordisk Inc
$122
Flowonix Medical Incorporated
$99
BioDelivery Sciences International, Inc.
$97
Biohaven Pharmaceuticals, Inc.
$73
Scilex Pharmaceuticals Inc.
$69
Curonix LLC
$62
SCILEX PHARMACEUTICALS INC.
$58
ARBOR PHARMACEUTICALS, INC.
$53
Azurity Pharmaceuticals, Inc.
$49
RedHill Biopharma Inc.
$39
IBSA Pharma Inc.
$36
Vertos Medical, Inc.
$31
Lilly USA, LLC
$27
Bioventus LLC
$26
ABBVIE INC.
$26
Hikma Pharmaceuticals USA
$24
Teva Pharmaceuticals USA, Inc.
$20
Amgen Inc.
$18
SPR Therapeutics, Inc
$18
Zyla Life Sciences, Inc.
$15
Horizon Therapeutics plc
$15
DePuy Synthes Sales Inc.
$15
Averitas Pharma Inc.
$15
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$14
Arbor Pharmaceuticals, Inc.
$12
Top 3 companies account for 45.0% of total payments
Associated products mentioned in payments ›
ACCOLADE SR · AJOVY · AXIUM · Aimovig · BELBUCA · BOTOX · Belbuca · DUEXIS · EMGALITY · ETERNA · Evoke · Evoke SCS · General - Pain Management · HA MINUTEMAN G3-R · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · KYPHON Balloon Kyphoplasty · Kloxxado · LICART · MONOVISC · Movantik · NURTEC ODT · Nalu Neurostimulation System · Nucynta · Omnia · PAINTEQ · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Proclaim IPG · Prometra II · Prospera · QUTENZA · Qutenza · RELISTOR · RESTORE · ReActiv8 · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SYNCHROMED · Saxenda · Senza · Senza Spinal Cord Stimulation System · Supartz FX Sodium Hyaluronate · Superion · Superion Indirect Decompression System · Tirosint · UBRELVY · V-LOC 180 · VANTA ADAPTIVESTIM · Vanta · WaveWriter Alpha Prime 16 · XTAMPZA · ZTLido · mild Device Kit · movantik
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for anesthesiology in TX.

Equivalent to $696 per 100 Medicare services performed
Looking for an anesthesiology specialist in Houston?
Compare anesthesiologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse anesthesiologists nearby

Geographic Context

Anesthesiologists within 10 mi
1,036
Per 100K population
21.8
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE SOUTHEAST
2.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Simpson is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX), with low-engagement industry engagement in the top 3% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Simpson experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Simpson performed 338 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Simpson receive payments from pharmaceutical companies?
Yes. Dr. Simpson received a total of $13,479 from 42 companies across 312 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Simpson's costs compare to other anesthesiologists in Houston?
Dr. Simpson's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Simpson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →